Regeneus secures commercial rights for breakthrough stem cell technology – Proactive Investors Australia
Proactive Investors Australia |
Regeneus secures commercial rights for breakthrough stem cell technology
Proactive Investors Australia The technology developed by researchers at the Australian Research Council's Centre of Excellence for Nanoscale BioPhotonics (CNBP) at Macquarie allows high potency secreting stem cells for the first time ever to be identified and selected for the … Regeneus Ltd (ASX:RGS) High Potency Stem Cells for Next Generation Cell Therapies |
